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Eating disorders, such as anorexia nervosa and
bulimia nervosa, are common and severe mental ill-
nesses of unknown etiology. Recently, we identified
a rare missense mutation in the transcription factor
estrogen-related receptor alpha (ESRRA) that is
associatedwith the development of eating disorders.
However, little is known about ESRRA function in the
brain. Here, we report that Esrra is expressed in the
mouse brain and demonstrate that Esrra levels are
regulated by energy reserves. Esrra-null female
mice display a reduced operant response to a high-
fat diet, compulsivity/behavioral rigidity, and social
deficits. Selective Esrra knockdown in the prefrontal
and orbitofrontal cortices of adult female mice reca-
pitulates reduced operant response and increased
compulsivity, respectively. These results indicate
that Esrra deficiency in the mouse brain impairs
behavioral responses in multiple functional domains.INTRODUCTION
While eating disorders (EDs) are known to result from a complex
interaction of environmental stress and genetic vulnerability
(Kaye et al., 2013), the specific neural substrates that mediate
development of EDs remain poorly understood. To elucidate
molecular pathways that lead to the development of EDs, we
previously conducted next-generation sequencing of two large
families with multiple members affected by EDs (Cui et al.,
2013). In that study, we identified rare missense mutations
in the estrogen-related receptor alpha (ESRRA) and histone de-
acetylase 4 (HDAC4) genes that significantly increase the risk
of having an ED (Cui et al., 2013). Specifically, the ESRRAR188Q
mutation reduces induction of known ESRRA-target genes
in vitro, while the HDAC4A786T mutation increases transcriptional
repression of ESRRA by HDAC4. As both mutations result in344 Cell Reports 11, 344–350, April 21, 2015 ª2015 The Authorsdecreased ESRRA transcriptional activity, we hypothesized
that loss of ESRRA activity confers specific susceptibility to
developing an ED.
While ESRRA is known to be expressed in the CNS, relatively
little is known about its function in neurons. Esrra is also required
for induction of mitochondrial biogenesis in the brain, in
response to the peroxisome proliferator-activated receptor
gamma agonist rosiglitazone (Strum et al., 2007). Furthermore,
parkin, a protein associated with the development of Parkinson’s
disease, regulates Esrra levels through ubiquitination and degra-
dation of Esrra by the proteasome, which decreases expression
of the Esrra-target genes monoamine oxidase A and B
(Ren et al., 2011). Recently, Esrra has also been implicated in
mediating increased expression of the Fdnc5 and Bdnf genes
in mouse hippocampus following endurance exercise (Wrann
et al., 2013). Taken together, these findings suggest that tight
control of Esrra levels in the CNS may regulate multiple meta-
bolic processes critical to neuronal function. In the present
study, we examine Esrra function in mouse brain by using
genetic methods to examine the behavioral consequences of
loss of Esrra expression.
RESULTS
To study the role of Esrra in the brain, we performed immunohis-
tochemistry to determine its expression pattern in the whole
mouse brain. Esrra is abundantly expressed in several cortical
regions, including orbitofrontal cortex, medial prefrontal cortex
(mPFC), and cingulate cortex (Figures 1A–1C). Additionally,
Esrra is highly expressed in the primary and secondary somato-
sensory cortex, piriform cortex, retrosplenial granular cortex,
hippocampus, thalamus, mammillary nucleus, cerebellum, and
several brainstem nuclei involved in transmission of sensory
information (Figures S1A–S1C). Moderate levels of expression
are observed in dorsolateral aspects of the striatum, septum,
global pallidus, lateral hypothalamic area, and some midbrain
structures including tegmentum and substantia nigra. Very
limited expression was observed in the bed nuclei of stria
terminalis, amygdala, and the remainder of the hypothalamus,
Figure 1. Esrra-Null Mice Display Impaired
Behavioral Responses to Calorie Restric-
tion
(A–C) Expression of Esrra in 14-week-old C57BL6/
Jmice in lateral orbitofrontal, mPFC, and cingulate
cortex.
(D and E) 60% calorie restriction for 10 days in-
creases Esrra expression in mouse brain. Magni-
fication shows retrosplenial region of cingulate
cortex.
(F and G) Wild-type (n = 7) and Esrra-null (n = 6)
littermate mice were trained to lever press for a
HFD pellet on a fixed ratio and then tested for total
lever presses (F) and reward earned (G) on a pro-
gressive ratio under calorie restriction and ad lib
feeding conditions.
Data are presented as mean ± SEM. *p < 0.05,
**p < 0.01, and ***p < 0.001 indicate significant
differences between groups (Student’s t test). See
also Figure S1.regions that have been traditionally associated with a role in
feeding regulation. Double-immunohistochemistry staining of
Esrra and glial fibrillary acid protein failed to reveal colocalization
of Esrra in glia (data not shown).
Upregulation of Esrra expression has been observed in periph-
eral tissues following calorie restriction (Ranhotra, 2009). Thus,
we examined whether Esrra expression in brain would also be
increased in this same condition. Ten days of 60% calorie re-
striction significantly increased the intensity of Esrra staining
throughout the brain, including the cortex (Figures 1D, 1E,
S1D, and S1E), indicating that Esrra activity may be involved
in the response to energy balance. To quantify this effect, we
performed quantitative real-time PCR to measure the relative
abundance of Esrra mRNA in the cortex. Consistent with immu-
nohistochemical analysis, 60% calorie restriction induced a
significant increase in Esrra mRNA abundance in the cortex
compared to that in mice housed under ad lib feeding conditions
(2.48 ± 0.59 versus 4.93 ± 0.50, n = 6/group, p = 0.0098).
After determining Esrra expression in several mouse brain re-
gions and that Esrra expression is regulated bymetabolic status,
we examined the behavioral consequences of Esrra loss. A pre-
vious study reported that chow-fed male and female Esrra-null
mice were 15% smaller than wild-type littermates and dis-
played reduced weight gain on a high-fat diet (HFD), which is
consistent with the clinical diagnosis of anorexia nervosa whereCell Reports 11, 344–3body weight is maintained at or below
85% of ideal body weight (Luo et al.,
2003). We also verified that Esrra-null
mice were 15% smaller than wild-type
littermates and consumed less chow
and HFD (data not shown); however,
these phenotypes were identified in ani-
mals on an ad libitum diet. As the magni-
tude of ad libitum food intake primarily
reflects intra-meal satiety independent
of any component of behavioral effort
(Perello et al., 2010), we utilized instru-mental responding as a more sensitive measure of motivation
to obtain a HFD.
Following a fixed-ratio training session, wild-type and Esrra-
null mice were advanced to a progressive-ratio schedule in
which obtaining each successive HFD pellet required an
increased number of lever presses. Effortful responding for a
HFD was then assessed during both caloric restriction and ad li-
bitum feeding conditions by measuring the total number of lever
presses and total number of pellets earned during the 2-hr ses-
sion. During caloric restriction, Esrra-null mice exhibited reduced
total lever presses and number of reward obtained compared to
wild-type littermates (Figures 1F and 1G). Following re-feeding,
total lever presses and reward obtained decreased for both
groups as expected, and no significant differences were noted
between treatment groups. At the end of testing, we measured
fasting glucose and body composition to control for differences
in energy reserves that might account for the decreased re-
sponding in Esrra-null mice. Fasting glucose levels (Figure S1F)
and body composition (Figure S1G) were not different for both
groups, indicating that reduced effortful responding observed
in Esrra-null mice was not secondary to differences in energy
reserves.
In separate cohorts of female mice, we performed a battery of
behavioral tasks relevant to mental illness including locomotor
activity, depression/anxiety, compulsivity/behavioral rigidity,50, April 21, 2015 ª2015 The Authors 345
and impairments in social functioning. Esrra-null mice have
recently been reported to have reduced locomotion in both
treadmill exercise and voluntary activity in a metabolic cage
assessment (Perry et al., 2014). As locomotor activity varies
greatly depending on the context, we measured activity under
three conditions: voluntary wheel running, home-cage activity,
and exploration of a novel environment. When given free access
to a running wheel for 5 days, Esrra-null mice exhibited normal
circadian patterns of activity but also a reduction in total revolu-
tions (Figure 2A). Using the Laboras system, we assessed home-
cage activity and found a modest reduction in locomotion in
Esrra-null mice compared to wild-type littermates (Figure 2B).
Finally, we evaluated exploration of a novel environment by
measuring distance traveled in the elevate-plus-maze model of
anxiety-like behavior and found no significant difference be-
tween the groups (Figure 2C). This finding is important as thema-
jority of behavioral tests that we performed involved activity
within a novel environment.
We assessed anxiety- and depression-like behaviors using
the elevated-plus-maze and forced-swim test models. Female
Esrra-null mice do not display any differences in overall activity
or time on the open arm in the elevated-plus-maze (Figures 2C
and 2D); however, they did exhibit reduced immobility in the
forced-swim test (Figure 2E). Several tasks modeling aspects
of perseveration and behavioral rigidity in mice have been
used to study related neuropsychiatric disorders, such as
autism and obsessive-compulsive disorder, including compul-
sive grooming (Shmelkov et al., 2010; Welch et al., 2007; Xu
et al., 2013), marble burying (Angoa-Pe´rez et al., 2013), and
reversal learning (Kim et al., 2011). Using a vibration-plate
based system to quantify 24-hr home-cage grooming, we
observed that loss of Esrra increases grooming in female mice
(Figure 2F). The fact that chronic fluoxetine treatment has
been shown to reduce repetitive grooming in several other ge-
netic models of compulsivity (Shmelkov et al., 2010; Welch
et al., 2007) led us to assess whether this treatment could
also ameliorate the increased repetitive grooming in female
Esrra-null mice. Separate groups of Esrra-null female mice
were tested for baseline grooming and then randomized into
two equal groups that received either fluoxetine or saline
vehicle. Following 1 week of treatment, no effect of fluoxetine
was noted (saline 88.2% ± 12.1% versus fluoxetine 93.0% ±
8.9%, n = 6/group, p = 0.71). We also assessed behavioral
compulsivity in Esrra-null mice using the marble-burying
test. Consistent with the compulsive grooming results, female
Esrra-null mice showed a significantly greater degree of
marble-burying behaviors after 30 min than wild-type littermates
(Figure 2G). Mice were trained for 4 days to find an escape hole
in the Barnes maze to assess hippocampal-dependent memory
formation. On the fifth day, a probe trial was performed showing
that both wild-type and Esrra-null mice spent more time in the
area of the escape hole without a significant difference noted
between the groups. Following this initial training, mice were
next subjected to an additional 4 days of training in which the
escape hole was relocated to the opposite position. Another
probe trial was then performed, and time spent at the old and
new target was measured. While both groups learned the loca-
tion of the new escape hole, Esrra-null mice spent significantly346 Cell Reports 11, 344–350, April 21, 2015 ª2015 The Authorsmore time at the original target (Figure 3H), an indication of
behavioral rigidity.
Several tasks modeling social dysfunction in mice have been
designed, including the three-chamber social interaction, social
dominance, and novel object recognition. Using this battery of
tasks, we also found that Esrra-null mice displayed reduced
preference for interaction with a novel social target (Figure 2I),
increased social subordination (Figure 2J), and no differences
in novel object recognition as compared with wild-type littermate
mice. Together these behavioral findings indicate that Esrra-null
mice exhibit behavioral deficits in multiple domains including
decreasedmotivation for HFD, perseveration/ behavioral rigidity,
and impaired social functioning.
We next interrogated the neural circuits underlying the behav-
ioral phenotypes exhibited by Esrra-null mice by abrogating
expression of this gene in a region-specific manner in wild-
type female mice. Using viral-mediated gene transfer to selec-
tively knockdown expression of Esrra by short hairpin RNA
(shRNA)-mediated silencing (Figures S2A–S2D), we selected
several cortical regions implicated in the development of EDs
and ED-related behaviors, including cingulate cortex, orbitofron-
tal cortex, and medial prefrontal cortex (mPFC) (Frank, 2013).
While knockdown of Esrra in the cingulate and orbitofrontal cor-
tex had no effect on HFD-induced weight gain in female mice,
knockdown in the mPFC reduced weight gain (Figure 3A) via
reduced intake of a HFD (Figure 3B).We tested a separate cohort
of mice to assess whether knockdown of Esrra in the mPFC
disrupted operant responding for HFD. Consistent with our ob-
servations in Esrra-null mice, knockdown of Esrra in mPFC
was sufficient to reduce total lever presses and reward earned
(Figure 3C). Subsequent analyses also examined the capacity
of knockdown of Esrra within selected cortical fields to repro-
duce other behavioral phenotypes observed in null mutants.
Increased grooming was observed only after knockdown of
Esrra in orbitofrontal cortex, whereas no differences in grooming
were observed following either cingulate or mPFC knockdown
(Figure 3D). Reduced immobility was observed only after knock-
down of Esrra in the cingulate cortex (Figure 3E). Together, these
findings identify specific neural substrates accounting for the
behavioral alterations observed in Esrra-null mice.
Finally, we determined whether there was a sexual dimor-
phism in any of the changes we observed in female Esrra-null
mice by conducting all of the testing on male mice as well.
Table 1 summarizes the differences in behavioral phenotypes
in female and male Esrra-null mice. Similar to female mice,
male Esrra-null mice display reduced locomotor activity,
decreased operant responding, and reduced immobility in the
forced-swim test, but do not exhibit deficits in the compul-
sive/behavioral rigidity battery of tasks or the three chamber
social interaction test.
DISCUSSION
In the current study, we examine the forebrain distribution and
function of Esrra, a gene identified in human genetic studies of
EDs. We report that Esrra-null mice display behavioral impair-
ments relevant, including maintaining body weight at 15% below
normal, impaired behavioral responses to caloric restriction,
Figure 2. Behavioral Deficits in Esrra-Null Mice
(A) Voluntary wheel-running activity for female wild-type (WT) and Esrra-null mice for 5 days (n = 3 WT, 6 Esrra null).
(B) Time spent active in home cage as measured by vibration plate (n = 17 WT, 5 Esrra null).
(C and D) Distance moved and time spent on the open arm of the elevated-plus-maze (n = 8 WT, 14 null).
(E) Time immobile in the forced-swim test (n = 8 WT, 14 null).
(F) Home-cage grooming as measured by vibration plate (n = 17 WT, 5 Esrra null).
(G) Number of marbles buried within 30 min (n = 7 WT, 12 Esrra null).
(H) Time spent near old target and new target in Barnes maze (n = 5 WT, 6 Esrra null).
(I) Time spent with novel mouse in three-chamber test (n = 8 WT, 10 Esrra null).
(J) Time spent with novel object (n = 9 WT, 11 Esrra null).
(K) Percentage of victories in the social dominance test (n = 24 unique pairings).
Data presented as mean ± SEM with *p < 0.05, **p < 0.01 indicating significant differences between groups (two-way ANOVA [A] or Student’s t test [B–I and K]),
except for (J), which is presented as a percentage of total victories with ***p < 0.001 indicating significant differences between groups (chi-square test).compulsivity/behavioral rigidity, and impaired social functioning.
Furthermore, knockdown of Esrra expression within selected
cortical subfields distinguished regional specificity for circuitryunderlying behavioral deficits identified in Esrra-null mutants.
These findings show that Esrra dysfunction in select forebrain
regions impairs behaviors relevant to psychiatric disorders andCell Reports 11, 344–350, April 21, 2015 ª2015 The Authors 347
Figure 3. Knockdown of Esrra Expression by shRNA in Cortex Produces Region-Specific Behavioral Deficits
(A) Body-weight gain in female C57BL6/J mice on a HFD after AAV delivery into cingulate (n = 10 scramble and 9 shRNA-Esrra), orbitofrontal (n = 9 scramble and
10 shRNA-Esrra), or mPFC (n = 9 scramble and 11 shRNA-Esrra).
(B) Intake of a HFD after Esrra knockdown in mPFC.
(C) A separate cohort of mice received AAV into mPFC and was tested for total lever presses and reward earned.
(D and E) Mice from (A) were tested for home-cage grooming (D) and immobility in the forced-swim test (E).
Data presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 indicate significant differences between groups (ANOVA [A] or Student’s t test [B–E]). See
also Figure S2.offer insight into the potential role of Esrra dysfunction in the
development of eating disorders, such as anorexia nervosa.
Esrra expression in brain is increased during calorie restriction
and loss of Esrra by conventional knockout or shRNA-mediated
knockdown in the mPFC results in decreased consumption of a
HFD and decreased operant responding for a HFD. These results
suggest that increased expression of Esrra is important for
mediating behavioral responses to negative energy balance.
As the ESRRAR188Q mutation that was found to be associated
with an increased risk of developing anorexia nervosa results
in decreased transcriptional activity (Cui et al., 2013), our results
suggest that loss of ESRRA activity in humans may predispose
to the development of anorexia nervosa by impairing behavioral
responses to calorie restriction.
Identifying the neural circuit that mediates the reduced effort-
ful responding for HFD after fasting is another question of great
clinical relevance. Esrra activity in themPFC seems to be at least348 Cell Reports 11, 344–350, April 21, 2015 ª2015 The Authorspartially required for this effect, as viral-mediated knockdown of
Esrra expression in the mPFC produces a similar reduction in re-
sponding (Figure 3C). Stimulation of glutamatergic neurons in the
mPFC by pharmacological (Mena et al., 2013) or optogenetic
(Land et al., 2014) approaches potently induces food intake in
rodents. However, the site of this action is unclear as mPFC neu-
rons project to multiple sites, including the amygdala, lateral-
perifornical hypothalamic area, and nucleus accumbens that
have been implicated in this behavioral response (Land et al.,
2014; Mena et al., 2013). Recently developed chemogenetic
and optogenetic approaches to the study of feeding may ulti-
mately be required to deconstruct these circuits.
Additionally, the behavioral deficits we observe in Esrra-null
mice might have important implications for other symptoms
associated with the development of eating disorders. Neuropsy-
chological testing has consistently found that patients with EDs
display increased perseveration and behavioral rigidity (Roberts
Table 1. Summary of Behavioral and Electrophysiological
Phenotypes in Female and Male Esrra-Null Mice
Femalea Maleb
Operant responding
Lever presses decrease decrease
Rewards decrease decrease
Wheel running decrease no difference
Home-cage activity decrease decrease
Elevated plus maze
Distance traveled no difference no difference
Time on open arm no difference no difference
Forced-swim test decrease decrease
Grooming increase no difference
Marble burying increase no difference
Reversal learning decrease no difference
Three chamber test decrease no difference
Social dominance decrease decrease
Novel object no difference no difference
See also Table S1.
aResults for female mice from Figures 1 and 2.
bResults for male wild-type and Esrra-null littermate mice (n = 6–11/
group) tested under identical protocols.et al., 2010). Patients with EDs display deficits in social
functioning as well including insecure attachment, reduced
emotional awareness, increased avoidance of emotion, and in-
crease sense of social inferiority (Caglar-Nazali et al., 2014).
Our findings may also be relevant to the basis of sex differ-
ences observed in neuropsychiatric disorders. Many psychiatric
disorders, including EDs, major depression, and most anxiety
disorders, predominantly affect womenalthough the neural basis
of this sexual dimorphism remains unclear. Our data suggest that
femalesmay bemore susceptible to the loss of Esrra function, as
female knockout mice exhibited more behavioral impairments
thanmalemice. Themechanism for the observed sex differences
remains unclear. There is an estrogen response element in the
promoter of the Esrra gene, and previous studies have indicated
that estrogen receptor signaling affects expression of Esrra in
peripheral tissues (Bonnelye et al., 2002; Liu et al., 2003),
although we did not observe any change in Esrra mRNA levels
in mPFC 4 weeks after ovariectomy in young adult female mice
(data not shown). Alternatively, estrogen receptors alpha and
beta have been localized to dendritic spines in the hippocampus
andmay have a direct, non-genomic signaling effect on synaptic
plasticity (Sala and Segal, 2014). Delineating the roles of Esrra
and estrogen receptor activity will have important implications
in understanding sex-based differences in mental illness.
Several limitations of the current study should be noted. Esrra-
null mice have reduced locomotor activity, which can confound
the interpretation of certain behavioral tasks like operant re-
sponding and the forced-swim test. This hypolocomotor pheno-
type appears to be most severe for endurance activity, such as
treadmill exercise (Perry et al., 2014) or voluntary wheel running
(Figure 2A). The phenotype is less severe for home-cage activity
(Figure 2B) and absent in the exploration of a novel environment(Figure 2C), which represents the majority of our tasks. Also, we
have tried to select a balanced set of tasks to control for differ-
ences in locomotor activity. For instance, the increased activity
of Esrra-null mice in the forced-swim test, marble-burying test,
and grooming assay is in the opposite direction of an expected
hypolocomotor effect.
Finally, there are limitations with the two methods used to
decrease Esrra activity. We selected the Esrra-null mouse
because the ESRRAR188Q mutation that predisposes to the
development of eating disorders in human populations de-
creases transcriptional activity of Esrra in vitro (Cui et al.,
2013). While we believe that the Esrra-null mouse is a reasonable
first approach to testing our hypothesis that reduced Esrra
activity increases the risk of developing ED-related behaviors,
we cannot be certain that the R188Q mutation does not induce
an unanticipated change in the activity of the Esrra protein.
Additionally, the use of shRNA-mediated gene knockdown has
been questioned for possible off-target effects (Baek et al.,
2014). While this concern is offset by our limited use of shRNA
in the context of mapping behavioral deficits originally identified
in Esrra-null mice, the use of more targeted genetic models,
such as conditional deletion of Esrra expression with a Cre-lox
approach, will further expand our understanding of the genetic
necessity of Esrra within discrete neural circuits.
In conclusion, we show that loss of the transcription factor
Esrra results in behavioral deficits in multiple functional domains,
including maintenance of a low body weight, reduced effortful
responding for HFD after calorie restriction, compulsivity/behav-
ioral rigidity, and impaired social functioning. These findings
offer insight into the neurobiological function of Esrra and
have potential implications for understanding the neurobiolog-
ical basis of eating disorders.
EXPERIMENTAL PROCEDURES
Animals
Esrra-null and C57BL/6J mice were obtained from Jackson Laboratory and
backcrossedmore than five generations ontoC57BL/6J. All animal procedures
were performed in accordance with University of Iowa Institutional Animal
Care and Use Committee guidelines. Mice heterozygous for Esrra+/ alleles
were bred to generate wild-type (Esrra+/+) and Esrra-null (Esrra/) littermate
mice. Mice were weaned and genotyped at 3–4 weeks of age. See Supple-
mental Experimental Procedures for housing andanimal husbandry conditions.
Behavioral Studies
Twelve- to 16-week-old animals were used for behavioral studies. Some mice
were used after completing body-weight monitoring and had previously been
exposed to a high-fat diet (42.8% calories from fat, TD.88137, Harlan-Teklad).
No behavioral differences, however, were noted between chow- and HFD-fed
animals and groups (data not shown). Separate cohorts ofmice not exposed to
a HFD were used for wheel running and operant responding, respectively, so
that no mouse included in the other behavioral tasks had been exposed to in-
crease physical activity or calorie restriction. See Supplemental Experimental
Procedures for full methodology for behavioral experiments.
Immunohistochemistry
Immunohistochemistry was performed as previously reported (Cui et al.,
2012). Rabbit monoclonal anti-Esrra antibody was used (04-1134; Millipore)
at 1/1,000 dilution. The specificity of anti-Esrra antibody was confirmed by
both immunohistochemistry (Figure S1B) and immunoblotting (Figure S1C) in
Esrra-null mice. Quantification of immunohistochemistry was performed as
previously described (Yin et al., 2014).Cell Reports 11, 344–350, April 21, 2015 ª2015 The Authors 349
Viral Preparation
An shRNA sequence targeting nucleotides 1203–1223 of mouse Esrra
(NM_007953) or scramble control were commercially prepared (Vector Labo-
ratories). See Supplemental Experimental Procedures for full description of
viral preparations.
Viral Delivery
Twelve-week-old female C57BL/6J (The Jackson Laboratory, #00664) mice
were randomly assigned into two groups to receive either adeno-associated
virus 2 (AAV) encoding both mEsrra-shRNA and GFP or AAV encoding
scrambled sequence and GFP as control into the following regions: mPFC
(AP +1.8 mm, ML +0.8 mm, DV 2.8 mm, 10-degree angle), lateral orbitofron-
tal (AP +2.8 mm, ML +1.7 mm, DV 2.0 mm, 10-degree angle), and cingulate
(AP +0.2mm,ML +0.6mm, DV1.7mm, 10-degree angle). See Supplemental
Experimental Procedures for surgical procedures.
Data Analysis
Data are presented as mean ± SEM. GraphPad Prism 6 software (GraphPad)
were used to perform all statistical analyses. For feeding and wheel-running
studies, comparisons between groups were made by two-way ANOVA with
time as the repeated measure. The chi-square test was used to determine
significance in the social dominance test. Student’s t test was used for all other
measures. p < 0.05 was considered to be statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.03.032.
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